May 14, 2012

ALSIO VIEJO, Calif. – Cianna Medical, maker of the SAVI® breast brachytherapy applicator, recently announced the launch of BEST Forum, a new educational resource for physicians to obtain the latest findings and research in breast brachytherapy and gain insights into best practices and available technology.

Both online and in person, BEST Forum ( brings together world-renowned thought leaders in the field of breast cancer care to discuss their extensive experiences and research in brachytherapy, treatment and clinical outcomes.

Breast brachytherapy is a form of accelerated partial breast irradiation (APBI), a shortened course of radiation therapy for early-stage breast cancer patients following lumpectomy surgery.

At the BEST Forum website, which launched in early May, physicians can view presentations from brachytherapy experts, as well as download white papers, presentation slides and supporting clinical data, and register for future presentations.

“We’re excited to introduce this unique resource, as it enables physicians interested in breast brachytherapy to learn from their colleagues’ experiences while providing them with the tools to educate referring physicians in their own communities about the benefits of this accelerated treatment option,” said Jill Anderson, president and CEO of Cianna Medical.

Volume 1 of BEST Forum features radiation oncologist Robert Kuske, MD, FAACE, of Arizona Breast Cancer Specialists in Scottsdale, Ariz. In Practical Application of Patient Selection Criteria, Dr. Kuske discusses the origin and common misconceptions regarding the current patient selection guidelines from the American Society of Radiation of Oncology (ASTRO) for the use of APBI.

In addition to discussing his own experiences, Dr. Kuske reviews emerging data on APBI, focused on controversial subsets such as women with estrogen receptor (ER) negative tumors, ductal carcinoma in situ (DCIS) and younger age (<60 years). Dr. Kuske also explains how strut-based brachytherapy can expand the ability to treat eligible patients where anatomical restrictions prevent the use of other forms of breast brachytherapy.

Dr. Kuske previously led the breast cancer program at the University of Wisconsin and was chairman of Radiation Oncology at the famed Ochsner Clinic in New Orleans. While in New Orleans, Dr. Kuske and colleagues pioneered accelerated partial breast irradiation, and he is now a co-principal investigator of the North American 4300 patient phase III trial through the NSABP and RTOG, approved and funded by the National Cancer Institute.

Volume 2, Lower Toxicities with Strut-based Brachytherapy: 4-year Results, will be released in July 2012. Catheryn Yashar, MD, a radiation oncologist at UC San Diego Moores Cancer Center in La Jolla, Calif., will provide an in-depth analysis on published data from the SAVI Collaborative Research Group, including acute and late toxicity, local recurrence rates and how strut-based brachytherapy can expand patient eligibility for APBI.

The published data has been presented at several medical conferences in 2012, including the American College of Radiation Oncology (ACRO), the American Society of Breast Disease (ASBD), and the American Brachytherapy Society (ABS) World Congress of Brachytherapy.

Dr. Yashar is associate professor of radiation oncology at the UC San Diego School of Medicine and chief of breast and gynecological radiation services at the UCSD Moores Cancer Center. Her clinical and research focus has centered on cancers in women, notably breast and gynecologic cancers. She is currently a co-principal investigator of the SAVI Collaborative Research Group.

Visit for more information.

About Cianna Medical, Inc.

Cianna Medical, Inc. is a medical device company focused on women’s health and dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and markets the SAVI breast brachytherapy applicator, for the delivery of radiation after lumpectomy surgery. The applicator allows precise sculpting of the radiation dose, and is designed to make the benefits of accelerated partial breast irradiation available to a greater number of women.

For more information, call (toll-free) 866-920-9444 or visit

Contact: Liz Dowling, (415) 388-2794
Dowling & Dennis Public Relations